Breast Cancer Survivorship Biorepository

This observational study is creating a collection of blood samples and health information from women who have survived breast cancer. The goal is to build a resource, called a biorepository, for future research. This biorepository will help scientists look for connections between a person's individual characteristics, their genes, and how their cancer journey unfolds. You may be able to join if you are a woman aged 18 or older, diagnosed with stage I-III invasive breast cancer within the past 7 years, and have finished active treatment (like surgery, chemotherapy, HER2-directed therapy, and radiation). The main goal is to establish this biorepository, which will be measured at 5 years.

Study design
This is an observational study aiming to enroll 1300 participants. It is not a treatment study but focuses on collecting data and samples.
What's involved
You would complete surveys, have blood samples collected, and allow researchers to review your medical records.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint, the biorepository, is measured at 5 years, suggesting data collection over this period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05786664

Breast Cancer Survivorship Biorepository

Recruiting
Not specifiedAges 18+Observational
University of Southern California
~1,300 participants
Updated 2026-05-28 on ClinicalTrials.gov
What's tested:Biospecimen CollectionElectronic Health Record ReviewQuality-of-Life AssessmentSurvey Administration

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Biorepository
Measured over 5 years
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic Stage III Breast Cancer AJCC v8
Invasive Breast Carcinoma
1 sites across 1 states
California1
  • Bodour Salhia, PhD · PRINCIPAL_INVESTIGATOR · University of Southern California

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Women of all racial and ethnic groups 18 years of age or older
Women with a diagnosis of invasive breast cancer (stages I-III) within the past 7 years
Women who have completed active treatment for breast cancer (surgery, chemotherapy, HER2-directed therapy and radiation)
Prior participation on clinical trials is allowed

Exclusion

Current receipt of interventional clinical trial participation
Stage IV (metastatic) cancer
Prior history of recurrence (except recurrence following ductal carcinoma in situ)
Inability to give informed consent
Unable to speak English, Spanish, Chinese, or Korean
  • Biorepository5 years

    Number of biological samples collected and stored (blood)